Compare Heron Therapeutics Inc (HRTX) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Lithium Americas Corp — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Lithium Americas Corp trades at $3.27 (market cap $1.18B). The key difference: Lithium Americas Corp is far larger — about 19.2× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | LAC | |
|---|---|---|
Market Cap | $61.47M | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $1.49 | $10.05 |
52-Week Low | $0.32 | $2.71 |
Enterprise Value | $168.21M | $1.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
